Trial Profile
A Randomized, Controlled Trial of Adding Intravenous Pantoprazole to Conventional Treatment for the Immediate Relief of Dyspeptic Pain.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Aug 2012
Price :
$35
*
At a glance
- Drugs Pantoprazole (Primary) ; Aluminium hydroxide; Magnesium hydroxide; Scopolamine butylbromide
- Indications Dyspepsia; Gastro-oesophageal reflux; Visceral pain
- Focus Therapeutic Use
- 25 Jul 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health: NCT01281501).
- 04 Jun 2012 New trial record
- 28 Mar 2012 Results published in the American Journal of Emergency Medicine.